Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Jan 2, 2022
Climate change is also a very real public health emergency
The impact of global warming has been considerable on people of all ages, particularly the most vulnerable and those with underlying health conditions.
Japan Times
JAPAN / Science & Health
Dec 29, 2021
Tokyo researchers work toward 'dream' COVID-19 vaccine that gives protection for life
By repurposing the vector used in the long-proven smallpox vaccine, Michinori Kohara hopes to offer more enduring COVID-19 protection against variants that have yet to develop.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
COMMENTARY / World
Dec 22, 2021
Biden can promise action, but omicron is in charge right now
The U.S. president's biggest policy promise during the 2020 campaign was perhaps his vow to attack COVID-19 in a professional and competent way.
Japan Times
JAPAN / FOCUS
Dec 21, 2021
Ivermectin for COVID? Unproven treatment stokes concern in Japan
Although the treatment has received some support from Japan's medical establishment and studies are ongoing, ivermectin is not approved as a COVID-19 remedy in the country.
Japan Times
JAPAN
Dec 18, 2021
Japan to shorten booster shot interval for medical workers and seniors on omicron concerns
The interval between second shots and booster shots will be six months for health care workers and those living in nursing homes, the prime minister said.
Japan Times
EDITORIALS
Dec 17, 2021
Safety and security are key to a new Go To Travel campaign
The prospect of a recovery from COVID-19 and a vaccine and pills that can protect against future infection has prompted the Kishida government to restart the Go To Travel program.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
COMMENTARY / World
Dec 16, 2021
Omicron should be a wake-up call for the world
Almost no low-income countries are on track to meet the World Health Organization's goal of vaccinating 40% of their populations by the end of this year.
Japan Times
COMMENTARY / World
Dec 15, 2021
Omicron scrambles what we know about immunity
If this thing keeps growing exponentially and infects millions of people in a short time, health systems could collapse, even if a tinier fraction of cases are serious.
Japan Times
WORLD
Dec 15, 2021
Pfizer says COVID-19 pill near 90% protective against hospitalization and death
Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.
Japan Times
JAPAN / Science & Health
Dec 10, 2021
Japan researchers use ostrich cells to make glowing COVID-19 detection masks
The discovery could help advance low-cost, at-home testing, and may potentially help those suffering from allergies and other ailments.
Japan Times
COMMENTARY / World
Dec 8, 2021
How the U.S. can rein in skyrocketing drug prices
Negotiated prices on many medications would introduce an important new form of cost control in uncompetitive corners of the U.S. prescription-drug market.
Japan Times
WORLD / Science & Health
Dec 7, 2021
New COVID-19 pills offer hope as omicron looms
Two new antiviral pills are coming soon, and are expected to work against all versions of the virus.
Japan Times
COMMENTARY / World
Dec 5, 2021
Who’s afraid of evidence-based policymaking?
As societies struggle to reopen in the shadow of new COVID-19 variants, social experiments are urgently needed to ensure that we implement policies with proven records of success.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.
Japan Times
EDITORIALS
Dec 3, 2021
Omicron is a wake-up call to fix vaccine inequality
The most important factor in COVID-19's evolution and the threat its variants pose is the size of unvaccinated populations and the reservoirs in which they can develop.
Japan Times
JAPAN / FOCUS
Dec 2, 2021
Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay
After being one of the last major developed nations to approve Pfizer's vaccine, Japan's drug regulator is looking to ease approval requirements for future pandemics.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?